Company Filing History:
Years Active: 2024
Title: Mark Midei: Innovator in ALS Treatment
Introduction
Mark Midei is a notable inventor based in Los Altos, California. He has made significant contributions to the field of medicine, particularly in the treatment of amyotrophic lateral sclerosis (ALS). His innovative approach combines various therapeutic methods to inhibit the progression of this debilitating disease.
Latest Patents
Mark Midei holds a patent for a synergistic combination therapy for treating ALS. This patent discloses methods for inhibiting the progression of ALS in humans. The methods utilize a synergistic combination of methyl-phenyl-pyrazoline-one and deuterated arachidonic acid or a prodrug thereof, such as 11,11-D2-linoleic acid or an ester thereof. This innovative therapy represents a promising advancement in ALS treatment.
Career Highlights
Mark Midei is associated with Biojiva LLC, where he continues to work on groundbreaking research and development in the medical field. His dedication to improving patient outcomes through innovative therapies has positioned him as a key figure in ALS research.
Collaborations
Mark collaborates with talented individuals such as Peter Milner and Nadia Litterman. Their combined expertise enhances the research efforts at Biojiva LLC, fostering an environment of innovation and discovery.
Conclusion
Mark Midei's contributions to ALS treatment through his patented methods highlight his commitment to advancing medical science. His work not only showcases his inventive spirit but also offers hope to those affected by ALS.